Bristol-Myers Squibb

NYSE: BMY · Real-Time Price · USD
48.47
0.66 (1.38%)
At close: Aug 15, 2025, 3:59 PM
48.44
-0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

Bristol-Myers Squibb Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
10.35B 11.46B 9.12B 13.98B
Short-Term Investments
513M 816M 130M 3.24B
Long-Term Investments
2.51B 2.5B 2.19B 2.71B
Other Long-Term Assets
2.36B 1.43B 1.04B 1.66B
Receivables
14.42B 15.26B 13.94B 12.52B
Inventory
2.56B 2.66B 2.34B 2.1B
Other Current Assets
1.94B 1.56B 1.74B 1.43B
Total Current Assets
29.78B 31.77B 27.27B 33.26B
Property-Plant & Equipment
8.36B 8.04B 7.47B 6.97B
Goodwill & Intangibles
45.36B 48.65B 57.5B 63.28B
Total Long-Term Assets
62.82B 63.39B 69.55B 76.05B
Total Assets
92.6B 95.16B 96.82B 109.31B
Account Payables
3.6B 3.26B 3.04B 2.95B
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
2.05B 3.12B 4.26B 4.95B
Other Current Liabilities
14.6B 12.79B 11.99B 11.48B
Total Current Liabilities
23.77B 22.26B 21.89B 21.87B
Long-Term Debt
47.6B 36.65B 35.06B 39.6B
Other Long-Term Liabilities
2.87B 4.59B 5.05B 6.13B
Total Long-Term Liabilities
52.44B 43.41B 43.81B 51.44B
Total Liabilities
76.22B 65.67B 65.7B 73.31B
Total Debt
51.2B 41.46B 40.72B 45.6B
Common Stock
292M 292M 292M 292M
Retained Earnings
14.91B 28.77B 25.5B 23.82B
Comprehensive Income
-1.24B -1.55B -1.28B -1.27B
Shareholders Equity
16.34B 29.43B 31.06B 35.95B
Total Investments
3.02B 3.31B 2.32B 5.96B